Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
49
# OF OVERLAPPING
HOLDINGS
WDNA
85
HOLDINGS
62%
ALSO IN IBB
IBB
260
HOLDINGS
24%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.9% | 2.7% | 2.7% |
|
AMGEN INC | 2.2% | 7.6% | 2.2% |
|
GILEAD SCIENCES INC | 1.7% | 7.8% | 1.7% |
|
UNITED THERAPEUTICS CORP | 2.3% | 1.7% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 1.4% | 8.7% | 1.4% |
WDNA Overweight Relative to IBB
|
ELI LILLY & CO | 3.1% |
|
JOHNSON & JOHNSON | 2.7% |
|
PFIZER INC | 2.4% |
|
STOKE THERAPEUTICS, INC. | 2.4% |
|
REGENXBIO, INC. | 2.2% |
 |
NOVO NORDISK A/S-B | 2.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.1% |
|
NOVOZYMES A/S-B SHARES | 2.0% |
|
BEAM THERAPEUTICS, INC. | 1.9% |
|
IMMUNOME, INC. | 1.9% |
WDNA Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -7.3% |
|
GILEAD SCIENCES INC | -6.0% |
|
REGENERON PHARMACEUTICALS | -5.8% |
|
AMGEN INC | -5.4% |
|
ALNYLAM PHARMACEUTICALS INC | -4.0% |
|
INSMED INC | -3.2% |
|
BEIGENE LTD. SPONSORED ADR | -2.1% |
|
INCYTE CORP | -1.8% |
 |
ARGENX SE ADR | -1.7% |
|
BIOGEN IDEC INC | -1.7% |